Research Article

A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer

Table 2

Meta-analysis of the R521K polymorphism with risk of cancer.

AA versus GGGA versus GGAA versus GA + GGAA + GA versus GGA versus G
OR (95% CI) (%)OR (95% CI) (%)OR (95% CI) (%)OR (95% CI) (%)OR (95% CI) (%)

Overall130.85 [0.74, 0.99]0.25190.121.04 [0.87, 1.25]740.670.99 [0.91, 1.08]0.8400.921.02 [0.86, 1.21]0.0001690.601.06 [0.95, 1.18]0.0001690.28
Cancer type
 Breast cancer40.94 [0.65, 1.38]0.22320.771.41 [0.77, 2.60]890.270.99 [0.88, 1.10]0.8800.801.40 [0.78, 2.50]890.261.18 [0.84, 1.64]0.0007830.33
 Colorectal cancer30.81 [0.42, 1.58]0.18420.980.85 [0.47, 1.55]0.03700.601.04 [0.83, 1.31]0.9700.720.85 [0.52, 1.38]0.08610.510.92 [0.72, 1.18]0.21350.78
 Gastric cancer20.94 [0.55, 1.59]0.26210.560.91 [0.61, 1.34]0.26210.480.97 [0.72, 1.30]0.4300.820.90 [0.52, 1.56]0.11600.711.43 [1.19, 1.72]0.4900.001
 Hepatocellular carcinoma21.01 [0.66, 1.57]0.12580.950.95 [0.57, 1.59]0.05730.851.05 [0.85, 1.30]0.7000.650.98 [0.61, 1.57]0.06730.921.03 [0.90, 1.18]0.18450.68
 Other cancers20.93 [0.61, 1.40]0.27170.751.12 [0.89, 1.40]0.6400.330.91 [0.68, 1.21]0.23300.521.07 [0.87, 1.32]0.9600.521.01 [0.87, 1.17]0.6700.90
Ethnicity
 Arab30.65 [0.34, 1.26]0.29190.131.05 [0.78, 1.42]0.4500.740.58 [0.34, 1.01]0.9100.060.97 [0.73, 1.28]0.7600.830.90 [0.72, 1.12]0.8700.35
 Asian50.91 [0.79, 1.05]0.32150.200.91 [0.76, 1.10]0.06570.350.99 [0.90, 1.09]0.9600.850.91 [0.76, 1.09]0.04600.301.06 [0.91, 1.25]0.0004800.44
 Caucasian31.18 [0.57, 2.45]0.13500.661.34 [0.43, 4.19]920.621.05 [0.84, 1.32]0.7500.651.40 [0.48, 4.09]920.541.21 [0.68, 2.15]0.0005870.51
 Other ethnicities21.15 [0.59, 2.27]0.4600.681.33 [0.91, 1.96]0.7200.141.09 [0.57, 2.07]0.5000.791.33 [0.92, 1.92]0.8600.131.18 [0.90, 1.55]0.8300.22

: number of studies, OR (95% CI): odds ratio (95% confidence interval), and : values of -test for heterogeneity test. Random effects model was used when or %; otherwise fixed effect model was used.